Two possible metabolic blocks in DNA synthesis that could be mutagenic

On the mutagenic action of adenine.

Leukemia research·2007

Mutagenic mechanisms in leukemia and cancer: a new concept Cytosine lack could be as mutagenic as cytosine deamination.

Leukemia research·2006

On the pathogenesis of erythroleukaemia (H0493).

Leukemia research·2004

The non-random distribution of point mutations in leukaemia and myelodysplasia--a possible pointer to their aetiology.

Leukemia research·1997

Folate responsive neuropathy.

Presse medicale (Paris, France : 1983)·1994

Serum valine, methionine and isoleucine levels in patients anaesthetized with and without nitrous oxide.

Clinical and laboratory haematology·1985

Cladribine-based salvage therapy in relapsed/refractory AML: A multicenter retrospective study.

Leukemia research·2026

Stemness-driven INTS7 overexpression links metabolic comorbidity to chemoresistance in acute myeloid leukemia with type 2 diabetes.

Leukemia research·2026

SLC1A5 and NUMA1 are potential regulators and therapeutic targets of ferroptosis in diffuse large B-cell lymphoma.

Leukemia research·2026

Feasibility of blinatumomab in newly diagnosed pediatric B-cell acute lymphoblastic leukemia patients requiring modification of standard chemotherapy.

Leukemia research·2026

Treatment outcome in pediatric patients with T-ALL in Brazil.

Leukemia research·2026

Arterial stiffness in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors: An exploratory prospective observational study.

Leukemia research·2026

Identification of a novel small-molecule modulator targeting SNX10 to inhibit osteoclastic bone resorption.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

Outcomes of target therapies for pediatric BRAF V600-mutant low-grade gliomas: A systematic review and meta-analysis.

Neuro-oncology advances·2026

Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression.

PeerJ·2026

Titanium dioxide nanoparticle-modified screen-printed electrode for erlotinib determination.

ADMET & DMPK·2026

Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.

MedComm·2026

Recurrence distance analysis for clinical target volume optimization in glioblastoma.

Clinical and translational radiation oncology·2026

Related Experiment Videos

Two possible metabolic blocks in DNA synthesis that could be mutagenic

Related Concept Videos

On the mutagenic action of adenine.

Mutagenic mechanisms in leukemia and cancer: a new concept Cytosine lack could be as mutagenic as cytosine deamination.

On the pathogenesis of erythroleukaemia (H0493).

The non-random distribution of point mutations in leukaemia and myelodysplasia--a possible pointer to their aetiology.

Folate responsive neuropathy.

Serum valine, methionine and isoleucine levels in patients anaesthetized with and without nitrous oxide.

Cladribine-based salvage therapy in relapsed/refractory AML: A multicenter retrospective study.

Stemness-driven INTS7 overexpression links metabolic comorbidity to chemoresistance in acute myeloid leukemia with type 2 diabetes.

SLC1A5 and NUMA1 are potential regulators and therapeutic targets of ferroptosis in diffuse large B-cell lymphoma.

Feasibility of blinatumomab in newly diagnosed pediatric B-cell acute lymphoblastic leukemia patients requiring modification of standard chemotherapy.

Treatment outcome in pediatric patients with T-ALL in Brazil.

Arterial stiffness in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors: An exploratory prospective observational study.

Identification of a novel small-molecule modulator targeting SNX10 to inhibit osteoclastic bone resorption.

Outcomes of target therapies for pediatric BRAF V600-mutant low-grade gliomas: A systematic review and meta-analysis.

Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression.

Titanium dioxide nanoparticle-modified screen-printed electrode for erlotinib determination.

Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.

Recurrence distance analysis for clinical target volume optimization in glioblastoma.

Related Experiment Videos

Two possible metabolic blocks in DNA synthesis that could be mutagenic

Related Concept Videos

Related Articles